104 related articles for article (PubMed ID: 29051151)
1. Understanding lymphoma molecular complexity.
Pileri SA
Blood; 2017 Oct; 130(16):1780-1781. PubMed ID: 29051151
[No Abstract] [Full Text] [Related]
2. Learning from the failures of drug discovery in B-cell non-Hodgkin lymphomas and perspectives for the future: chronic lymphocytic leukemia and diffuse large B-cell lymphoma as two ends of a spectrum in drug development.
Kubuschok B; Trepel M
Expert Opin Drug Discov; 2017 Jul; 12(7):733-745. PubMed ID: 28494631
[TBL] [Abstract][Full Text] [Related]
3. Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma.
Klapper W; Kreuz M; Kohler CW; Burkhardt B; Szczepanowski M; Salaverria I; Hummel M; Loeffler M; Pellissery S; Woessmann W; Schwänen C; Trümper L; Wessendorf S; Spang R; Hasenclever D; Siebert R;
Blood; 2012 Feb; 119(8):1882-7. PubMed ID: 22238326
[TBL] [Abstract][Full Text] [Related]
4. [Diffuse Large B cell Lymphoma - Modern Dia-gnostics and Molecularly Targeted Treatment].
Pytlík R; Trněný M
Klin Onkol; 2015; 28 Suppl 3():3S64-72. PubMed ID: 26489504
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of CD44v6 in diffuse large B-cell lymphoma.
Inagaki H; Banno S; Wakita A; Ueda R; Eimoto T
Mod Pathol; 1999 May; 12(5):546-52. PubMed ID: 10349995
[TBL] [Abstract][Full Text] [Related]
6. Composite Epstein-Barr virus-positive mucosa-associated lymphoid tissue lymphoma and Epstein-Barr virus-negative diffuse large B-cell lymphoma in the parotid salivary gland of a patient with Sjögren's syndrome and rheumatoid arthritis: a case report.
Gorodetskiy VR; Probatova NA; Konovalov DM; Ryzhikova NV; Sidorova YV; Sudarikov AB; Mukhortova OV
J Med Case Rep; 2020 Jan; 14(1):12. PubMed ID: 31948469
[TBL] [Abstract][Full Text] [Related]
7. Lymphoma classification update: B-cell non-Hodgkin lymphomas.
Jiang M; Bennani NN; Feldman AL
Expert Rev Hematol; 2017 May; 10(5):405-415. PubMed ID: 28395545
[TBL] [Abstract][Full Text] [Related]
8. Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and Treatment.
Crombie JL; Armand P
Hematol Oncol Clin North Am; 2019 Aug; 33(4):575-585. PubMed ID: 31229155
[TBL] [Abstract][Full Text] [Related]
9. Primary Diffuse Large B-cell Lymphoma involving the Mandible.
Alshahrani FA; Aljabab AS; Motabi IH; Alrashed A; Anil S
J Contemp Dent Pract; 2015 Oct; 16(10):840-4. PubMed ID: 26581467
[TBL] [Abstract][Full Text] [Related]
10. New insights into the biology of molecular subtypes of diffuse large B-cell lymphoma and Burkitt lymphoma.
Frick M; Dörken B; Lenz G
Best Pract Res Clin Haematol; 2012 Mar; 25(1):3-12. PubMed ID: 22409819
[TBL] [Abstract][Full Text] [Related]
11. Novel targeted therapies in diffuse large B-cell lymphoma.
Mehta-Shah N; Younes A
Semin Hematol; 2015 Apr; 52(2):126-37. PubMed ID: 25805592
[TBL] [Abstract][Full Text] [Related]
12. The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection.
Arcaini L; Rossi D; Lucioni M; Nicola M; Bruscaggin A; Fiaccadori V; Riboni R; Ramponi A; Ferretti VV; Cresta S; Casaluci GM; Bonfichi M; Gotti M; Merli M; Maffi A; Arra M; Varettoni M; Rattotti S; Morello L; Guerrera ML; Sciarra R; Gaidano G; Cazzola M; Paulli M
Haematologica; 2015 Feb; 100(2):246-52. PubMed ID: 25381127
[TBL] [Abstract][Full Text] [Related]
13. Molecular subtyping of diffuse large B-cell lymphoma: update on biology, diagnosis and emerging platforms for practising pathologists.
Gifford GK; Gill AJ; Stevenson WS
Pathology; 2016 Jan; 48(1):5-16. PubMed ID: 27020203
[TBL] [Abstract][Full Text] [Related]
14. Diffuse large B-cell lymphoma with oral manifestations.
Bulut E; Bekçioğlu B; Günhan O; Sener I
J Craniofac Surg; 2011 May; 22(3):1144-7. PubMed ID: 21586973
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence and clinico-pathological characteristics in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma in a high complexity hospital in Cali, Columbia].
Amaya D; Moreno JC; Calvache N; Castro A; Pérez B; Silva N
Rev Esp Patol; 2019; 52(3):139-146. PubMed ID: 31213254
[TBL] [Abstract][Full Text] [Related]
16. Utilization of pathway signatures to reveal distinct types of B lymphoma in the Emicro-myc model and human diffuse large B-cell lymphoma.
Mori S; Rempel RE; Chang JT; Yao G; Lagoo AS; Potti A; Bild A; Nevins JR
Cancer Res; 2008 Oct; 68(20):8525-34. PubMed ID: 18922927
[TBL] [Abstract][Full Text] [Related]
17. [Unclassifiable B-cell lymphoma: Between diffuse large B-cell lymphoma and Burkitt lymphoma].
Mahdi Y; Malihy A; Kettani F; Alaammari I; Khmou M; Touri S; Rouas L; Lamalmi N; El Khorassani M; Alhamany Z
Arch Pediatr; 2015 Jun; 22(6):661-4. PubMed ID: 25934611
[No Abstract] [Full Text] [Related]
18. [Advances in the Molecular Diagnosis and Therapy of Relapsed/Refractory Diffuse Large B-cell Lymphoma -Review].
Wang Y; Xia B; Zhang YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):603-608. PubMed ID: 29665940
[TBL] [Abstract][Full Text] [Related]
19. Diffuse large B-cell lymphoma variants: an update.
Sukswai N; Lyapichev K; Khoury JD; Medeiros LJ
Pathology; 2020 Jan; 52(1):53-67. PubMed ID: 31735345
[TBL] [Abstract][Full Text] [Related]
20. CXCL9 promotes the progression of diffuse large B-cell lymphoma through up-regulating β-catenin.
Ruiduo C; Ying D; Qiwei W
Biomed Pharmacother; 2018 Nov; 107():689-695. PubMed ID: 30130730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
